Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed tw...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Mol Hepatol
Päätekijät: Song, Byung-Cheol, Cho, Yoo-Kyung, Jwa, Hyeyoung, Choi, Eun Kwang, Kim, Heung Up, Song, Hyun Joo, Na, Soo-Young, Boo, Sun-Jin, Jeong, Seung Uk
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Association for the Study of the Liver 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278066/
https://ncbi.nlm.nih.gov/pubmed/25548741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.4.355
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia